Director

Claire Pomeroy, M.D.

Director (Lead Director effective as of the 2026 Annual Meeting)·Embecta Corp.

About

Dr. Pomeroy has served since 2013 as President of the Albert and Mary Lasker Foundation, a private foundation that seeks to improve health by accelerating support for medical research through recognition of research excellence, public education and advocacy. Prior thereto, she served as Dean and Vice Chancellor of the University of California, Davis School of Medicine. She is an elected member of the National Academy of Medicine. Dr. Pomeroy is a member of the Board of Directors of Haemonetics Corporation (NYSE: HAE).

Since 2022
Tenure 4 yrs

Also at Embecta Corp.

CA Carrie L. Anderson Director RH Robert (Bob) J. Hombach Director DK Devdatt (Dev) Kurdikar President and Chief Executive Officer, Embecta Corp. MP Milton M. Morris, Ph.D. Director KP Karen N. Prange Director CR Christopher R. Reidy Director

Past roles

No prior roles disclosed
The proxy statement discloses no roles beyond this person's current position. Disclosure is required only for the most recent five years.

Director compensation

Data from FY 2025
Fees earned or paid in cash
$96,000
Stock awards
$230,004
All other compensation
$7,000
Total
$333,004

Related

Source: Embecta Corp. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo